drugset / Trial / NCT05333835

A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

NCT05333835

Phase 2 Unknown 455 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this trial is to compare the efficacy and safety of HR17031 versus INS068 and SHR20004 in subjects with type 2 diabetes.

Timeline

Start
2022-07-08
Primary completion
2024-03-30
Completion
2024-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject HR17031 Unknown
Comparator INS068 Protein / enzyme biologic
Comparator SHR20004 Unknown